Measles (Rubeola) Antibody, IgM, CSF by IFA
Also known as: MEASLMCSF
Use
The detection of antibodies to rubeola in CSF can aid in diagnosing central nervous system infections such as measles encephalitis. However, the test should be performed only on individuals with a known exposure due to the possibility of false positive results.
Special Instructions
Testing is not approved by New York. Specimens from New York clients will be sent to a New York state-approved laboratory.
Limitations
Interpretation of the results must account for potential contamination by blood or the transfer of serum antibodies across the blood-brain barrier, which might interfere with the accuracy of the test.
Methodology
Immunoassay (Indirect Fluorescent Antibody)
Biomarkers
LOINC Codes
- 21502-0
Result Turnaround Time
1-5 days
Related Documents
For more information, please review the documents below
Specimen
Cerebrospinal Fluid
Volume
0.5 mL
Minimum Volume
0.2 mL
Container
ARUP standard transport tube
Storage Instructions
Refrigerated, also acceptable: Frozen
Causes for Rejection
Bacterially contaminated, heat-inactivated, hemolyzed, or xanthochromic specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 hours |
| Refrigerated | 2 weeks |
| Frozen | 1 month |